These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28941564)

  • 1. Cancer Therapy with Checkpoint Inhibitors: Establishing a Role for Ophthalmology.
    Davis ME; Francis JH
    Semin Oncol Nurs; 2017 Nov; 33(4):415-424. PubMed ID: 28941564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interprofessional Collaboration with Immune Checkpoint Inhibitor Therapy: the Roles of Gastroenterology, Endocrinology and Neurology.
    Seery V
    Semin Oncol Nurs; 2017 Nov; 33(4):402-414. PubMed ID: 28927760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Models of Interprofessional Collaboration in Cancer Care.
    Knoop T; Wujcik D; Wujcik K
    Semin Oncol Nurs; 2017 Nov; 33(4):459-463. PubMed ID: 28939373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Oncodermatology in the Care of Patients Receiving Cancer Therapy.
    Skripnik Lucas A; Ciccolini K
    Semin Oncol Nurs; 2017 Nov; 33(4):393-401. PubMed ID: 28943034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.
    Thompson JA; Schneider BJ; Brahmer J; Achufusi A; Armand P; Berkenstock MK; Bhatia S; Budde LE; Chokshi S; Davies M; Elshoury A; Gesthalter Y; Hegde A; Jain M; Kaffenberger BH; Lechner MG; Li T; Marr A; McGettigan S; McPherson J; Medina T; Mohindra NA; Olszanski AJ; Oluwole O; Patel SP; Patil P; Reddy S; Ryder M; Santomasso B; Shofer S; Sosman JA; Wang Y; Zaha VG; Lyons M; Dwyer M; Hang L
    J Natl Compr Canc Netw; 2022 Apr; 20(4):387-405. PubMed ID: 35390769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Checkpoint Inhibitor Toxicity Review for the Palliative Care Clinician.
    Hansen ED; Wang X; Case AA; Puzanov I; Smith T
    J Pain Symptom Manage; 2018 Sep; 56(3):460-472. PubMed ID: 29792979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for immune-related toxicities of checkpoint inhibitors: current progress and the road ahead.
    Patil PD; Burotto M; Velcheti V
    Expert Rev Mol Diagn; 2018 Mar; 18(3):297-305. PubMed ID: 29430978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generally speaking!
    Natarajan S
    Indian J Ophthalmol; 2015 Aug; 63(8):629. PubMed ID: 26576518
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical Diagnosis and Treatment Recommendations for Ocular Toxicities of Target Therapy and Immune Checkpoint Inhibitor Therapy].
    Liu X; Wang Z; Zhao C; Wang H; Guo X; Zhou J; Duan L; Si X; Zhang L; Li Y; Wang M; Shi J; Zhang M; Zhang L
    Zhongguo Fei Ai Za Zhi; 2019 Oct; 22(10):653-660. PubMed ID: 31650949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The concept of ophthalmologic oncology development].
    Brovkina AF; Zarubeĭ GD; Val'skiĭ VV
    Vestn Oftalmol; 2000; 116(5):16-8. PubMed ID: 11221370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the geriatrician, primary care practitioner, nurses, and collaboration with oncologists during cancer treatment delivery for older adults: A narrative review of the literature.
    Puts MTE; Strohschein FJ; Del Giudice ME; Jin R; Loucks A; Ayala AP; Alibhai SHM
    J Geriatr Oncol; 2018 Jul; 9(4):398-404. PubMed ID: 29747954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Future of Immunotherapy in the Treatment of Cancer.
    Kottschade LA
    Semin Oncol Nurs; 2019 Oct; 35(5):150934. PubMed ID: 31477413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular Toxicity of Tyrosine Kinase Inhibitors.
    Davis ME
    Oncol Nurs Forum; 2016 Mar; 43(2):235-43. PubMed ID: 26906134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interprofessional care and collaboration: are ophthalmologists and optometrists ready?
    Buys YM; Nicolela M
    Can J Ophthalmol; 2009 Jun; 44(3):254-6. PubMed ID: 19491976
    [No Abstract]   [Full Text] [Related]  

  • 15. [Problems posed during the management of ocular complications of diabetes].
    Slimane H; M'Kaouar A; Fourati S; Khiari K; Ftouhi B; Bouguerra R; Ben Slama C; Ezzaouia G; Ben Khelifa F
    Tunis Med; 1993 Dec; 71(12):581-5. PubMed ID: 8134960
    [No Abstract]   [Full Text] [Related]  

  • 16. Update on New Therapies With Immune Checkpoint Inhibitors.
    Peterson JJ; Steele-Moses SK
    Clin J Oncol Nurs; 2016 Aug; 20(4):405-10. PubMed ID: 27441513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 7th edition AJCC staging system for eye cancer: an international language for ophthalmic oncology.
    Finger PT;
    Arch Pathol Lab Med; 2009 Aug; 133(8):1197-8. PubMed ID: 19653708
    [No Abstract]   [Full Text] [Related]  

  • 18. The Role of Cardio-Oncology in the Interprofessional Care of Adult Patients Receiving Cancer Therapy.
    Pituskin E; Paterson I; Cox-Kennett N; Rothe D; Perri M; Becher H
    Semin Oncol Nurs; 2017 Nov; 33(4):384-392. PubMed ID: 28941563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer and the Immune System: The History and Background of Immunotherapy.
    Abbott M; Ustoyev Y
    Semin Oncol Nurs; 2019 Oct; 35(5):150923. PubMed ID: 31526550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European School of Oncology position paper. Gene therapy for the medical oncologist.
    Blaese M; Blankenstein T; Brenner M; Cohen-Haguenauer O; Gansbacher B; Sorrentino B; Velu T
    Eur J Cancer; 1995; 31A(9):1531-7. PubMed ID: 7577084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.